Difference between revisions of "Journal:Cyberbiosecurity for biopharmaceutical products"

From LIMSWiki
Jump to navigationJump to search
(Created stub. Saving and adding more.)
 
(Created stub. Saving and adding more.)
Line 6: Line 6:
|title_full  = Cyberbiosecurity for biopharmaceutical products
|title_full  = Cyberbiosecurity for biopharmaceutical products
|journal      = ''Frontiers in Bioengineering and Biotechnology''
|journal      = ''Frontiers in Bioengineering and Biotechnology''
|authors      = Mantle, Jennifer L.; Rammohan, Jayan; Romatseva, Eugenia F.; Welch, Joel T.; Kauffman, Leah R.; McCarthy, Jim; Schiel, John; Baker, Jeffrey C.; Strychalski, Elizabeth A.; Rogers, Kelley C; Lee, Kelvin H.
|authors      = Mantle, Jennifer L.; Rammohan, Jayan; Romatseva, Eugenia F.; Welch, Joel T.; Kauffman, Leah R.;<br />McCarthy, Jim; Schiel, John; Baker, Jeffrey C.; Strychalski, Elizabeth A.; Rogers, Kelley C; Lee, Kelvin H.
|affiliations = National Institute for Innovation in Manufacturing Biopharmaceuticals, National Institute of Standards and Technology, U.S. Food and Drug Administration
|affiliations = National Institute for Innovation in Manufacturing Biopharmaceuticals, National Institute of Standards and Technology,<br />U.S. Food and Drug Administration
|contact      = Email: KHL at udel dot edu
|contact      = Email: KHL at udel dot edu
|editors      = Murch, Randall S.
|editors      = Murch, Randall S.

Revision as of 17:12, 15 July 2019

Full article title Cyberbiosecurity for biopharmaceutical products
Journal Frontiers in Bioengineering and Biotechnology
Author(s) Mantle, Jennifer L.; Rammohan, Jayan; Romatseva, Eugenia F.; Welch, Joel T.; Kauffman, Leah R.;
McCarthy, Jim; Schiel, John; Baker, Jeffrey C.; Strychalski, Elizabeth A.; Rogers, Kelley C; Lee, Kelvin H.
Author affiliation(s) National Institute for Innovation in Manufacturing Biopharmaceuticals, National Institute of Standards and Technology,
U.S. Food and Drug Administration
Primary contact Email: KHL at udel dot edu
Editors Murch, Randall S.
Year published 2019
Volume and issue 7
Page(s) 116
DOI 10.3389/fbioe.2019.00116
ISSN 2296-4185
Distribution license Creative Commons Attribution 4.0 International
Website https://www.frontiersin.org/articles/10.3389/fbioe.2019.00116/full
Download https://www.frontiersin.org/articles/10.3389/fbioe.2019.00116/pdf (PDF)

Abstract

Cyberbiosecurity is an emerging discipline that addresses the unique vulnerabilities and threats that occur at the intersection of cyberspace and biotechnology. Advances in technology and manufacturing are increasing the relevance of cyberbiosecurity to the biopharmaceutical manufacturing community in the United States. Threats may be associated with the biopharmaceutical product itself or with the digital thread of manufacturing of biopharmaceuticals, including those that relate to supply chain and cyberphysical systems. Here, we offer an initial examination of these cyberbiosecurity threats as they stand today, as well as introductory steps toward paths for mitigation of cyberbiosecurity risk for a safer, more secure future.

Keywords: cyberbiosecurity, cybersecurity, biopharmaceutical manufacturing, engineering biology, cell therapy, gene therapy, supply chain

References

Notes

This presentation is faithful to the original, with only a few minor changes to presentation, grammar, and punctuation. In some cases important information was missing from the references, and that information was added.